Delivery Order SPE2DB22D9209-SPE2DB24FL5SV

Award Date 9/20/24
Potential Completion Date 10/11/24
Potential Value $4.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm fixed-price delivery order, awarded by the Defense Logistics Agency (DLA) on September 12, 2024, is for the supply of 100-unit vials of Botox (Botulinum Toxin Type A) to the U.S. Department of Defense (DoD). The contract has a ceiling value of $5,537.76 and an ultimate completion date of October 3, 2024. The prime contractor is DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. This award is part of DMS Pharmaceutical Group's larger indefinite...
This federal contract award is for the delivery of BOTOX 100 Unit Vials to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense (DoD). The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with a ceiling value of $87,966.00 and a completion date of October 14, 2022. It is part of a larger indefinite delivery contract (IDC)...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $13,844.40, is for the delivery of BOTOX 100 unit vials and has an ultimate completion date of September 4, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued at up to $499,999,999, that allows the...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $4,614.80, is for the delivery of BOTOX 100 unit vials to support the recurring pharmaceutical supply needs of military health facilities. The order is part of a larger indefinite delivery contract (IDC) with the DLA, valued up to $499,999,999, which runs through December 31, 2025. This...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of BOTOX 200 unit vials. The contract, valued at $64,685.00, has an ultimate completion date of September 9, 2024. This award is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group Inc., valued at up to $499,999,999, which runs through December 31, 2025. The IDC allows the DLA...
This contract award is for the delivery of BOTOX 100 unit vials to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense (DoD). The contract has a ceiling value of $4,614.80 and was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with no set-aside designation, issued under DMS Pharmaceutical Group's larger indefinite delivery...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $34,611.00, is for the delivery of BOTOX 100 unit vials to support the recurring medical supply needs of military health facilities. This delivery order is part of a larger single-award indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the...
This federal contract award is for the delivery of BOTOX 100 UNIT VIALS to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with a ceiling value of $48,569.85 and an ultimate completion date of April 15, 2025. The contract is not associated with any set-aside designation. DMS Pharmaceutical Group...
This federal contract award is for the delivery of BOTOX 100 UNIT VIALS to the Defense Logistics Agency (DLA), a defense agency, under a firm fixed-price delivery order. The contract, valued at $46,148.00, was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which has a total potential...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $4,614.80 to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of 100-unit vials of BOTOX. This order is placed under DMS Pharmaceutical Group's existing indefinite-delivery, indefinite-quantity (IDIQ) contract SPE2DB, valued at up to $4,999,999 through 2025, which allows DLA to issue delivery orders for a broad range of pharmaceutical products to support military...
  • SPE2DB22D9209
    Indefinite Delivery Contract
  • SPE2DB22D9209-SPE2DB24FL5SV
    Delivery Order

This federal contract award by the Defense Logistics Agency (DLA) is for the delivery of BOTOX 100 unit vials to the Department of Defense (DoD). The contract, which is a firm fixed-price delivery order, has a ceiling value of $4,614.80 and an ultimate completion date of October 11, 2024. The prime contractor is DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This contract is not set aside and is part of a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which has a ceiling value of up to $499,999,999 and runs through December 31, 2025. Through this IDC, DMS Pharmaceutical Group provides a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical supplies, to support the recurring medical needs of military health facilities worldwide.

Generated 12/20/24, 9:04 AM